DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Kalincik T, Brown JWL, Robertson N. et al.
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Lancet Neurol 2017;
16: 271-281 DOI: 10.1016/S1474-4422(17)30007-8 [Epub 2017 Feb 11]
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.